We investigated whether monocyte CD14 receptor gene promoter polymorphisms were associated with the development and severity of pre-eclampsia. We genotyped the CD14-260 C/T polymorphism in 36 preeclamptic patients and 52 healthy pregnant controls. A total of 30.6% and 69.4% of pre-eclamptic patients had the C and T alleles, respectively, and 48.0% and 52.0% of the controls, respectively. More pre-eclamptic patients were TT homozygotes compared with controls (50.0% versus 13.5%). In pre-eclamptic patients, the TT homozygotes exhibited a significantly higher mean systolic blood pressure compared with the non-TT homozygotes (173 ± 28 mmHg versus 153 ± 22 mmHg). We also noted a tendency towards increased proteinuria and placental abruption in the TT homozygotes compared with the non-TT homozygotes. We conclude that CD14 gene promoter polymorphisms appear to be a risk factor for pre-eclampsia. With further research, these findings might form the basis of a prognostic tool for pre-eclampsia.
SacksGPStudenaKSargentILRedmanCW: Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol1998; 179: 80–86.
4.
SacksGPSargentILRedmanCWG: An innate view of human pregnancy. Immunol Today1999; 20: 114–118.
5.
FaasMMSchuilingGABallerJFVisscherCABakkerWW: A new animal model for human preeclampsia: Ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol1994; 171: 158–164.
6.
SibaiBM: Preeclampsia: An inflammatory syndrome?Am J Obstet Gynecol2004; 191: 1061–1062.
7.
OianPOmsjoIMaltauJMOsterudB: Increased sensitivity to thromboplastin synthesis in blood monocytes from pre-eclamptic patients. Br J Obstet Gynaecol1985; 92: 511–517.
PuginJSchurer-MalyCCLeturcqDMoriartyAUlevitchRJTobiasPS: Lipopolysaccharide activation of endothelial and epithelial cells is mediated by lipopolysaccharides-binding protein and soluble CD14. Proc Natl Acad Sci U S A1993; 90: 2744–2748.
GoyertSMFerreroERettigWJYenamandraAKObataFLe BeauMM: The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science1988; 239: 497–500.
12.
ZhangDEHetheringtonCJTanSDziennisSEGonzalezDAChenHM: Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem1994; 269: 11425–11434.
13.
American College of Obstetricians and Gynecologists Committee on Obstetric Practice: ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol Obstet2002; 77: 67–75.
14.
MorangePETiretLSautNLucGArveilerDFerrieresJ: TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Eur J Hum Genet2004; 12: 1–9.
15.
RedmanCWSacksGPSargentIL: Pre-eclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol1999; 180: 499–506.
16.
Le VanTDBloomJWBailyTJKarpCLHalonenMMartinezFD: A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp1 protein binding and enhances transcriptional activity. J Immunol2001; 167: 5838–5844.
17.
KupfermincMJPeacemanAMWigtonTRRehnbergKASocolML: Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol1994; 170: 1752–1757.
18.
SaarelaTHiltunenMHalisalmiSHeinonenSLaaksoM. Tumor necrosis factor-alpha gene haplotype is associated with pre-eclampsia. Mol Hum Reprod2005; 11: 437–440.
19.
KaiserTGrehanMBrenneckeSPMosesEK: Association of the TNF2 allele with eclampsia. Gynecol Obstet Invest2004; 57: 204–209.
20.
HeiskanenJRomppanenELHiltunenMIivonenSMannermaaAPunnonenK: Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia. J Assist Reprod Genet2002; 19: 220–223.
21.
HubacekJARotheGPit'HaJSkodovaZStanekVPoledneR: C(−260)→ polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation1999; 99: 3218–3220.
22.
ShimadaKWatanabeYMokunoHIwamaYDaidaHYamaguchiH: Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol2000; 86: 682–684.
23.
GibotSCariouADrouetLRossignolMRipollL: Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med2002; 30: 969–973.
24.
KochWKastratiAMehilliJvon BeckerathNSchomigA: CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. Am Heart J2002; 143: 971–976.
25.
LichyCMeiserHGrond-GinsbachCGBuggleFDorferCGrauA: Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population. J Neurol2002; 249: 821–823.
26.
PachecoEFonsecaCMontesCZabaletaJGarciaLFAriasMA: CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunol Med Microbiol2004; 40: 207–213.
